Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tissue-specific Responses to Influenza Immunization
NCT03023709Phase 4Terminated
- Sponsor
- Stanford University
- Start
- Sep 2015
- Primary completion
- Dec 2015
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza, sponsored by Stanford University. Started Sep 2015; status: terminated.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03023709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03023709.